C4 Therapeutics, Inc. Long-Term Debt
C4 Therapeutics, Inc. (CCCC) had Long-Term Debt of $0 as of 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2024-02-22
- 2023-12-31: Long-term Debt, Excluding Current Maturities $0.00.
- 2023-09-30: Long-term Debt, Excluding Current Maturities $0.00.
- 2023-06-30: Long-term Debt, Excluding Current Maturities $0.00.
- 2023-03-31: Long-term Debt, Excluding Current Maturities $8.62M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-22 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-01 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 |
| 2023-03-31 | $8.62M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $9.20M 10-K · filed 2024-02-22 |
| 2022-09-30 | $9.05M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $10.37M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $10.19M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $10.77M 10-K · filed 2023-02-23 |
| 2021-09-30 | $10.59M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $10.41M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $10.23M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $10.05M 10-K · filed 2022-02-24 |
| 2020-09-30 | $9.88M 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |